PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jnmaLink to Publisher's site
 
J Natl Med Assoc. 2006 May; 98(5): 772–778.
PMCID: PMC2569293

Efficacy and safety of coadministration of ezetimibe and simvastatin in African-American patients with primary hypercholesterolemia.

Abstract

The purpose of this study was to examine the efficacy and safety of ezetimibe (EZE) coadministered with simvastatin (SIMVA) in a large cohort of African Americans with primary hypercholesterolemia. In a multicenter, randomized, double-blind study, patients were considered eligible for enrollment if after a washout/placebo run-in period, low-density-lipoprotein (LDL) cholesterol level was > or = 145 and < or = 250 mg/dl and triglyceride level was < or = 350 mg/dl. Eligible patients were randomized to SIMVA 20 mg coadministered with either EZE 10 mg (n = 124) or placebo (n = 123) for 12 weeks. At study endpoint, EZE/SIMVA 10/20 mg resulted in a significant mean percent reduction in LDL cholesterol from baseline of 45.6% compared with 28.3% for SIMVA 20 mg alone (p < or = 0.01). There were significantly greater mean reductions in total cholesterol (33% vs. 21%), triglycerides (median 22% vs. 15%), nonhigh-density-lipoprotein (non-HDL) cholesterol (42% vs. 26%), and apolipoprotein B (38% vs. 25%) with EZE/SIMVA 10/20 mg compared with SIMVA 20 mg alone, respectively (p < or = 0.01). There was no difference in HDL cholesterol between the EZE/SIMVA 10/20-mg and SIMVA 20-mg alone groups (+1% vs. +2%, respectively). Coadministration of EZE/SIMVA 10/20 mg demonstrated a safety profile similar to that of SIMVA 20 mg. In conclusion, EZE/SIMVA 10/20 mg provided significantly greater improvement in atherogenic lipid profiles and was well tolerated compared with SIMVA 20-mg monotherapy in a large cohort of African Americans with primary hypercholesterolemia.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486–2497. [PubMed]
  • Grundy Scott M. Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation. 2002 Jun 11;105(23):2696–2698. [PubMed]
  • Knopp RH. Drug treatment of lipid disorders. N Engl J Med. 1999 Aug 12;341(7):498–511. [PubMed]
  • Van Heek M, France CF, Compton DS, McLeod RL, Yumibe NP, Alton KB, Sybertz EJ, Davis HR., Jr In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461. J Pharmacol Exp Ther. 1997 Oct;283(1):157–163. [PubMed]
  • Knopp RH, Dujovne CA, Le Beaut A, Lipka LJ, Suresh R, Veltri EP. Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies. Int J Clin Pract. 2003 Jun;57(5):363–368. [PubMed]
  • Kerzner Boris, Corbelli John, Sharp Stephan, Lipka Leslie J, Melani Lorenzo, LeBeaut Alexandre, Suresh Ramachandran, Mukhopadhyay Pabak, Veltri Enrico P. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol. 2003 Feb 15;91(4):418–424. [PubMed]
  • Ballantyne Christie M, Houri John, Notarbartolo Alberto, Melani Lorenzo, Lipka Leslie J, Suresh Ramachandran, Sun Steven, LeBeaut Alexandre P, Sager Philip T, Veltri Enrico P, et al. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Circulation. 2003 May 20;107(19):2409–2415. [PubMed]
  • Melani Lorenzo, Mills Richard, Hassman David, Lipetz Robert, Lipka Leslie, LeBeaut Alexandre, Suresh Ramachandran, Mukhopadhyay Pabak, Veltri Enrico. Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Eur Heart J. 2003 Apr;24(8):717–728. [PubMed]
  • Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, Strony J, Suresh R, Veltri E. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract. 2004 Aug;58(8):746–755. [PubMed]
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed]
  • Sager Philip T, Melani Lorenzo, Lipka Leslie, Strony John, Yang Bo, Suresh Ramachandran, Veltri Enrico. Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein. Am J Cardiol. 2003 Dec 15;92(12):1414–1418. [PubMed]
  • Sager Philip T, Capece Rachel, Lipka Leslie, Strony John, Yang Bo, Suresh Ramachandran, Mitchel Yale, Veltri Enrico. Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients. Atherosclerosis. 2005 Apr;179(2):361–367. [PubMed]
  • Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem. 2001 Mar;47(3):444–450. [PubMed]
  • Ferdinand Keith C, Clark Luther T, Watson Karol E, Neal Ryan C, Brown Clinton D, Kong B Waine, Barnes Boisey O, Cox William R, Zieve Franklin J, Isaacsohn Jonathan, et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol. 2006 Jan 15;97(2):229–235. [PubMed]
  • Feldman Theodore, Koren Michael, Insull William, Jr, McKenney James, Schrott Helmut, Lewin Andrew, Shah Sukrut, Sidisin Michelle, Cho Meehyung, Kush Debra, et al. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals. Am J Cardiol. 2004 Jun 15;93(12):1481–1486. [PubMed]
  • Goldberg Anne C, Sapre Aditi, Liu Ji, Capece Rachel, Mitchel Yale B. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2004 May;79(5):620–629. [PubMed]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association